Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism

References

• Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10:467-78; PMID:20539306
   PubMed Web of Science ®Google Scholar
• Chien YH, Meyer C, Bonneville M. gammadelta T Cells: First Line of Defense and Beyond. Annu Rev Immunol 2014; 32:121-55; PMID:24387714; http://dx.doi.org/10.1146/annurev-immunol-032713-120216
   PubMed Web of Science ®Google Scholar
• Vantourout P, Hayday A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol 2013; 13:88-100; PMID:23348415
   PubMed Web of Science ®Google Scholar
• Hannani D, Ma Y, Yamazaki T, Dechanet-Merville J, Kroemer G, Zitvogel L. Harnessing gammadelta T cells in anticancer immunotherapy. Trends Immunol 2012; 33:199-206; PMID:22364810; http://dx.doi.org/10.1016/j.it.2012.01.006
   PubMed Web of Science ®Google Scholar
• Gomes AQ, Martins DS, Silva-Santos B. Targeting gammadelta T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res 2010; 70:10024-7; PMID:21159627; http://dx.doi.org/10.1158/0008-5472.CAN-10-3236
   PubMed Web of Science ®Google Scholar
• Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology. Cancer Res 2007; 67:5-8; PMID:17210676; http://dx.doi.org/10.1158/0008-5472.CAN-06-3069
   PubMed Web of Science ®Google Scholar
• Thurnher M, Nussbaumer O, Gruenbacher G. Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin Cancer Res 2012; 18:3524-31; PMID:22529099; http://dx.doi.org/10.1158/1078-0432.CCR-12-0489
   PubMed Web of Science ®Google Scholar
• Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, Abhyankar S, Lamb LS. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transp 2007; 39:751-7; PMID:17450185; http://dx.doi.org/10.1038/sj.bmt.1705650
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Smetak M, Schaefer-Eckart K, Kimmel B, Birkmann J, Einsele H, Kunzmann V. Successful adoptive transfer and in vivo expansion of haploidentical gammadelta T cells. J Transl Med 2014; 12:45; PMID:24528541; http://dx.doi.org/10.1186/1479-5876-12-45
   PubMed Web of Science ®Google Scholar
• Kronenberg M, Kinjo Y. Infection, autoimmunity, and glycolipids: T cells detect microbes through self-recognition. Immunity 2005; 22:657-9; PMID:15963780; http://dx.doi.org/10.1016/j.immuni.2005.06.001
   PubMed Web of Science ®Google Scholar
• Larocca A, Child JA, Cook G, Jackson GH, Russell N, Szubert A, Gregory WM, Brioli A, Owen RG, Drayson MT, et al. The impact of response on bone-directed therapy in patients with multiple myeloma. Blood 2013; 122:2974-7; PMID:23974194; http://dx.doi.org/10.1182/blood-2013-04-498139
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343:425-30; PMID:1967820; http://dx.doi.org/10.1038/343425a0
   PubMed Web of Science ®Google Scholar
• Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov 2007; 6:541-55; PMID:17585331; http://dx.doi.org/10.1038/nrd2221
   PubMed Web of Science ®Google Scholar
• Thurnher M, Gruenbacher G, Nussbaumer O. Regulation of mevalonate metabolism in cancer and immune cells. Biochim Biophys Acta 2013; 1831:1009-15; PMID:23524243; http://dx.doi.org/10.1016/j.bbalip.2013.03.003
   PubMed Web of Science ®Google Scholar
• Riganti C, Massaia M. Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stone. Oncoimmunology 2013; 2:e25770; PMID:24327936; http://dx.doi.org/10.4161/onci.25770
   PubMed Web of Science ®Google Scholar
• Hayday AC. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 2009; 31:184-96; PMID:19699170; http://dx.doi.org/10.1016/j.immuni.2009.08.006
   PubMed Web of Science ®Google Scholar
• Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003; 197:163-8; PMID:12538656; http://dx.doi.org/10.1084/jem.20021500
   PubMed Web of Science ®Google Scholar
• Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999; 340:737-8; PMID:10068336; http://dx.doi.org/10.1056/NEJM199903043400914
   PubMed Web of Science ®Google Scholar
• Clendening JW, Pandyra A, Boutros PC, El Ghamrasni S, Khosravi F, Trentin GA, Martirosyan A, Hakem A, Hakem R, Jurisica I, et al. Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci U S A 2010; 107:15051-6; PMID:20696928; http://dx.doi.org/10.1073/pnas.0910258107
   PubMed Web of Science ®Google Scholar
• Freed-Pastor WA, Mizuno H, Zhao X, Langerod A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, et al. Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway. Cell 2012; 148:244-58; PMID:22265415; http://dx.doi.org/10.1016/j.cell.2011.12.017
   PubMed Web of Science ®Google Scholar
• Li W, Kubo S, Okuda A, Yamamoto H, Ueda H, Tanaka T, Nakamura H, Yamanishi H, Terada N, Okamura H. Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2. J Immunother 2010; 33:287-96; PMID:20445349; http://dx.doi.org/10.1097/CJI.0b013e3181c80ffa
   PubMed Web of Science ®Google Scholar
• Tsuda J, Li W, Yamanishi H, Yamamoto H, Okuda A, Kubo S, Ma Z, Terada N, Tanaka Y, Okamura H. Involvement of CD56brightCD11c+ cells in IL-18-mediated expansion of human gammadelta T cells. J Immunol 2011; 186:2003-12; PMID:21239711; http://dx.doi.org/10.4049/jimmunol.1001919
   PubMed Web of Science ®Google Scholar
• Nussbaumer O, Gruenbacher G, Gander H, Komuczki J, Rahm A, Thurnher M. Essential requirements of zoledronate-induced cytokine and gammadelta T cell proliferative responses. J Immunol 2013; 191:1346-55; PMID:23794630; http://dx.doi.org/10.4049/jimmunol.1300603
   PubMed Web of Science ®Google Scholar
• Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012; 150:1235-48; PMID:22980983; http://dx.doi.org/10.1016/j.cell.2012.07.021
   PubMedGoogle Scholar
• Jin C, Henao-Mejia J, Flavell RA. Innate immune receptors: key regulators of metabolic disease progression. Cell Metab 2013; 17:873-82; PMID:23747246; http://dx.doi.org/10.1016/j.cmet.2013.05.011
   PubMed Web of Science ®Google Scholar
• Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Di Sano C, Salerno A. Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med 2003; 198:391-7; PMID:12900516; http://dx.doi.org/10.1084/jem.20030235
   PubMed Web of Science ®Google Scholar
• Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003; 101:4260-6; PMID:12576317; http://dx.doi.org/10.1182/blood-2002-11-3577
   PubMed Web of Science ®Google Scholar
• Boyman O, Krieg C, Homann D, Sprent J. Homeostatic maintenance of T cells and natural killer cells. Cell Mol Life Sci 2012; 69:1597-608; PMID:22460580; http://dx.doi.org/10.1007/s00018-012-0968-7
   PubMed Web of Science ®Google Scholar
• Ribot JC, Ribeiro ST, Correia DV, Sousa AE, Silva-Santos B. Human gammadelta Thymocytes Are Functionally Immature and Differentiate into Cytotoxic Type 1 Effector T Cells upon IL-2/IL-15 Signaling. J Immunol 2014; 192:2237-43; PMID:24489097; http://dx.doi.org/10.4049/jimmunol.1303119
   PubMed Web of Science ®Google Scholar
• Meraviglia S, Caccamo N, Salerno A, Sireci G, Dieli F. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells. J Immunol 2010; 185:1770-6; PMID:20592281; http://dx.doi.org/10.4049/jimmunol.1000966
   PubMed Web of Science ®Google Scholar
• Alexander AA, Maniar A, Cummings JS, Hebbeler AM, Schulze DH, Gastman BR, Pauza CD, Strome SE, Chapoval AI. Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clin Cancer Res 2008; 14:4232-40; PMID:18594005; http://dx.doi.org/10.1158/1078-0432.CCR-07-4912
   PubMed Web of Science ®Google Scholar
• Harly C, Guillaume Y, Nedellec S, Peigne CM, Monkkonen H, Monkkonen J, Li J, Kuball J, Adams EJ, Netzer S, et al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human gammadelta T-cell subset. Blood 2012; 120:2269-79; PMID:22767497; http://dx.doi.org/10.1182/blood-2012-05-430470
   PubMed Web of Science ®Google Scholar
• Vavassori S, Kumar A, Wan GS, Ramanjaneyulu GS, Cavallari M, El Daker S, Beddoe T, Theodossis A, Williams NK, Gostick E, et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells. Nat Immunol 2013; 14:908-16; PMID:23872678
   PubMed Web of Science ®Google Scholar
• Wang H, Henry O, Distefano MD, Wang YC, Raikkonen J, Monkkonen J, Tanaka Y, Morita CT. Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human Vgamma2Vdelta2 T Cells. J Immunol 2013; 191:1029-42; PMID:23833237; http://dx.doi.org/10.4049/jimmunol.1300658
   PubMed Web of Science ®Google Scholar
• Sandstrom A, Peigne CM, Leger A, Crooks JE, Konczak F, Gesnel MC, Breathnach R, Bonneville M, Scotet E, Adams EJ. The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vgamma9Vdelta2 T Cells. Immunity 2014; 40(4):490-500; PMID:24703779
   PubMed Web of Science ®Google Scholar
• Fiore F, Castella B, Nuschak B, Bertieri R, Mariani S, Bruno B, Pantaleoni F, Foglietta M, Boccadoro M, Massaia M. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid. Blood 2007; 110:921-7; PMID:17403919; http://dx.doi.org/10.1182/blood-2006-09-044321
   PubMed Web of Science ®Google Scholar
• Roelofs AJ, Jauhiainen M, Monkkonen H, Rogers MJ, Monkkonen J, Thompson K. Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. Br J Haematol 2009; 144:245-50; PMID:19016713; http://dx.doi.org/10.1111/j.1365-2141.2008.07435.x
   PubMed Web of Science ®Google Scholar
• Castella B, Riganti C, Fiore F, Pantaleoni F, Canepari ME, Peola S, Foglietta M, Palumbo A, Bosia A, Coscia M, et al. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vgamma9Vdelta2 T cells, alphabeta CD8+ T cells, regulatory T cells, and dendritic cells. J Immunol 2011; 187:1578-90; PMID:21753152; http://dx.doi.org/10.4049/jimmunol.1002514
   PubMed Web of Science ®Google Scholar
• Munz C, Steinman RM, Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 2005; 202:203-7; PMID:16027234; http://dx.doi.org/10.1084/jem.20050810
   PubMed Web of Science ®Google Scholar
• Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A 1996; 93:2588-92; PMID:8637918; http://dx.doi.org/10.1073/pnas.93.6.2588
   PubMed Web of Science ®Google Scholar
• Dunn SE, Youssef S, Goldstein MJ, Prod'homme T, Weber MS, Zamvil SS, Steinman L. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med 2006; 203:401-12; PMID:16476765; http://dx.doi.org/10.1084/jem.20051129
   PubMed Web of Science ®Google Scholar
• Gruenbacher G, Gander H, Nussbaumer O, Nussbaumer W, Rahm A, Thurnher M. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells. Cancer Res 2010; 70:9611-20; PMID:20947520; http://dx.doi.org/10.1158/0008-5472.CAN-10-1968
   PubMed Web of Science ®Google Scholar
• Nussbaumer O, Gruenbacher G, Gander H, Thurnher M. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by gammadelta T lymphocytes. Blood 2011; 118:2743-51; PMID:21673342; http://dx.doi.org/10.1182/blood-2011-01-328526
   PubMed Web of Science ®Google Scholar
• Correia DV, d'Orey F, Cardoso BA, Lanca T, Grosso AR, de Barros A, Martins LR, Barata JT, Silva-Santos B. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells. PLoS One 2009; 4:e5657; PMID:19479075
   PubMedGoogle Scholar
• Lindberg BG, Merritt EA, Rayl M, Liu C, Parmryd I, Olofsson B, Faye I. Immunogenic and antioxidant effects of a pathogen-associated prenyl pyrophosphate in Anopheles gambiae. PLoS One 2013; 8:e73868; PMID:23967351; http://dx.doi.org/10.1371/journal.pone.0073868
   PubMedGoogle Scholar
• Yao L, Zhang Y, Chen K, Hu X, Xu LX. Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox. PLoS One 2011; 6:e24684; PMID:21931812; http://dx.doi.org/10.1371/journal.pone.0024684
   PubMed Web of Science ®Google Scholar
• Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187:211-7; PMID:4746329
   PubMed Web of Science ®Google Scholar
• Ma Q, Wang Y, Lo AS, Gomes EM, Junghans RP. Cell density plays a critical role in ex vivo expansion of T cells for adoptive immunotherapy. J Biomed Biotechnol 2010; 2010:386545; PMID:20625484; http://dx.doi.org/10.1155/2010/386545
   PubMed Web of Science ®Google Scholar
• Morita CT, Lee HK, Wang H, Li H, Mariuzza RA, Tanaka Y. Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol 2001; 167:36-41; PMID:11418629; http://dx.doi.org/10.4049/jimmunol.167.1.36
   PubMed Web of Science ®Google Scholar
• Morita CT, Jin C, Sarikonda G, Wang H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 2007; 215:59-76; PMID:17291279; http://dx.doi.org/10.1111/j.1600-065X.2006.00479.x
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, Modlin RL, Brenner MB, Bloom BR, Morita CT. Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A 1994; 91:8175-9; PMID:8058775; http://dx.doi.org/10.1073/pnas.91.17.8175
   PubMed Web of Science ®Google Scholar
• Grunder C, van Dorp S, Hol S, Drent E, Straetemans T, Heijhuurs S, Scholten K, Scheper W, Sebestyen Z, Martens A, et al. gamma9 and delta2CDR3 domains regulate functional avidity of T cells harboring gamma9delta2TCRs. Blood 2012; 120:5153-62; PMID:23018643; http://dx.doi.org/10.1182/blood-2012-05-432427
   PubMed Web of Science ®Google Scholar
• Porcelli SA, Morita CT, Modlin RL. T-cell recognition of non-peptide antigens. Curr Opin Immunol 1996; 8:510-6; PMID:8794014; http://dx.doi.org/10.1016/S0952-7915(96)80039-2
   PubMed Web of Science ®Google Scholar
• Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 2004; 229:567-85; PMID:15229351
   PubMed Web of Science ®Google Scholar
• MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol 2013; 31:259-83; PMID:23298210; http://dx.doi.org/10.1146/annurev-immunol-032712-095956
   PubMed Web of Science ®Google Scholar
• Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140:821-32; PMID:20303873; http://dx.doi.org/10.1016/j.cell.2010.01.040
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Kepp O, Galluzzi L, Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 2012; 13:343-51; PMID:22430787; http://dx.doi.org/10.1038/ni.2224
   PubMed Web of Science ®Google Scholar
• Li W, Okuda A, Yamamoto H, Yamanishi K, Terada N, Yamanishi H, Tanaka Y, Okamura H. Regulation of Development of CD56(bright)CD11c(+) NK-like Cells with Helper Function by IL-18. PLoS One 2013; 8:e82586; PMID:24376549
   PubMedGoogle Scholar
• Sugie T, Murata-Hirai K, Iwasaki M, Morita CT, Li W, Okamura H, Minato N, Toi M, Tanaka Y. Zoledronic acid-induced expansion of gammadelta T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells. Cancer Immunol Immunother 2013; 62:677-87; PMID:23151944; http://dx.doi.org/10.1007/s00262-012-1368-4
   PubMed Web of Science ®Google Scholar
• Amrani YM, Gill J, Matevossian A, Alonzo ES, Yang C, Shieh JH, Moore MA, Park CY, Sant'Angelo DB, Denzin LK. The Paf oncogene is essential for hematopoietic stem cell function and development. J Exp Med 2011; 208:1757-65; PMID:21844206; http://dx.doi.org/10.1084/jem.20102170
   PubMed Web of Science ®Google Scholar
• Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Buccheri S, D'Asaro M, Gebbia N, et al. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 2007; 67:7450-7; PMID:17671215; http://dx.doi.org/10.1158/0008-5472.CAN-07-0199
   PubMed Web of Science ®Google Scholar
• Caccamo N, Dieli F, Wesch D, Jomaa H, Eberl M. Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells. J Leukoc Biol 2006; 79:663-6; PMID:16461739; http://dx.doi.org/10.1189/jlb.1105640
   PubMed Web of Science ®Google Scholar
• Rodriguez MW, Paquet AC, Yang YH, Erle DJ. Differential gene expression by integrin beta 7+ and beta 7- memory T helper cells. BMC Immunol 2004; 5:13; PMID: 15236665; http://dx.doi.org/10.1186/1471-2172-5-13
   PubMedGoogle Scholar
• Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Defining the human T helper 17 cell phenotype. Trends Immunol 2012; 33:505-12; PMID:22682163; http://dx.doi.org/10.1016/j.it.2012.05.004
   PubMed Web of Science ®Google Scholar
• Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, Town L, Ritchie DS, Colonna M, Andrews DM, Smyth MJ. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat Immunol 2014; 15(5):431-8; http://dx.doi.org/10.1038/ni.2850.  [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Dickson RB, Willingham MC, Pastan IH. Receptor-mediated endocytosis of alpha 2-macroglobulin: inhibition by ionophores and stimulation by Na+ and HCO3(-). Ann N Y Acad Sci 1982; 401:38-49; PMID:6188403; http://dx.doi.org/10.1111/j.1749-6632.1982.tb25705.x
   PubMed Web of Science ®Google Scholar
• Cohnen A, Chiang SC, Stojanovic A, Schmidt H, Claus M, Saftig P, Janßen O, Cerwenka A, Bryceson YT, Watzl C. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood 2013; 122:1411-8; PMID:23847195; http://dx.doi.org/10.1182/blood-2012-07-441832
   PubMed Web of Science ®Google Scholar
• Gruenbacher G, Gander H, Rahm A, Nussbaumer W, Romani N, Thurnher M. CD56+ human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses. Blood 2009; 114:4422-31; PMID:19762486; http://dx.doi.org/10.1182/blood-2009-06-227256
   PubMed Web of Science ®Google Scholar